Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 50Completed 15Recruiting 3Not yet recruiting 3Terminated 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 2Non-small Cell Lung Cancer Metastatic 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × icotinib × Clear all
NCT06517953 2024-07-25

IcomBine

Sun Yat-sen University

Phase 2 Recruiting
23 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Betta Pharmaceuticals Co., Ltd.

Phase 3 Recruiting
570 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Peking University Cancer Hospital & Institute

Phase 2 Recruiting
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡